Bayesian Capital Management’s Nikola Corporation Common Stock NKLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-16,560
Closed -$517K 1161
2024
Q1
$517K Buy
16,560
+11,167
+207% +$240K 0.05% 426
2023
Q4
$142K Buy
+5,393
New +$168K 0.02% 640
2023
Q2
Sell
-1,650
Closed -$59.9K 1113
2023
Q1
$59.9K Buy
+1,650
New +$108K 0.01% 709
2022
Q3
Sell
-3,330
Closed -$476K 1071
2022
Q2
$476K Buy
+3,330
New +$681K 0.09% 349
2022
Q1
Sell
-2,196
Closed -$650K 956
2021
Q4
$650K Buy
+2,196
New +$733K 0.21% 145
2021
Q2
Sell
-1,327
Closed -$553K 691
2021
Q1
$553K Buy
1,327
+667
+101% +$380K 0.13% 210
2020
Q4
$302K Sell
660
-4,989
-88% -$3.11M 0.08% 302
2020
Q3
$3.47M Buy
+5,649
New +$6.58M 0.85% 13

Other funds holding NKLA

Bayesian Capital Management's NKLA Position: Q2 2024 in Review

Bayesian Capital Management sold out of Nikola Corporation Common Stock (NKLA) in Q2 2024, closing a stake of 16,560 shares — an estimated $517K sold.

Bayesian Capital Management first reported a position in NKLA in Q3 2020 and held it in 8 quarters. The position peaked at $3.47M in Q3 2020. 159 funds tracked by Wall St. Rank hold NKLA as of Q2 2024.

  • Bayesian Capital Management reported no remaining Nikola Corporation Common Stock position as of Q2 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 16,560 Nikola Corporation Common Stock shares in Q2 2024, an estimated $517K.
  • Bayesian Capital Management first reported a position in Nikola Corporation Common Stock in Q3 2020 and held it in 8 quarters.
  • Bayesian Capital Management's Nikola Corporation Common Stock position peaked at $3.47M in Q3 2020.
  • 159 funds tracked by Wall St. Rank held Nikola Corporation Common Stock as of Q2 2024.

Based on Bayesian Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.